KEY FINDINGS
The global marine biotechnology market is expected to grow at a CAGR of 5.48% for the forecast period of 20172026. The market value is expected to increase from $4343 million in 2016 and reach $7321 million by 2026. The growing use of marine biotechnology in cosmetic industry, emerging research in the area of marine biomaterials and the developing healthcare sector are majorly responsible for driving the global marine biotechnology market.
MARKET INSIGHTS
The Global marine biotechnology market is divided on the basis of Products and End users. The products market is segmented into biomaterial, bioactive substances, and others. The enduser market is bifurcated into industrial products, healthcare/Biotechnology, consumers' products, Energy Infrastructure, and others. The market also classified into technology which includes cultureindependent techniques, enrichment, isolation, and cultivation of microorganism, and largescale implementation. The healthcare segment has the highest demand in the marine biotechnology market owing to the high demands of bioactive products produced by microbes, gorgonians, sponges, soft and hard corals seaweeds, and other marine organisms.
REGIONAL INSIGHTS
Geographically, the global marine biotechnology market has been segmented into North America which includes U.S. Canada. The AsiaPacific include countries like China, India, Japan, and Rest of APAC, and the Europe region consists of UK, France, Germany, Spain, Italy, Nordics and Rest of Europe. The rest of the world include Latin America, Middle East and North Africa and Rest of Africa.
The North America marine biotechnology market is expected to hold the highest share by the end of the forecast years. An extensive research for marine biofuels in the North American countries coupled with the growing biomaterialbased medical applications in knee implants, bone morph genic proteins, artificial ligaments, bone plates, and dental implants are boosting the market in this region. On the other hand, the AsiaPacific market which is anticipated to be the fastestgrowing region in the marine biotechnology market on account of its huge exports of marine food products. China is the world's largest exporter of seafood with 12% share in seafood exports globally. Other factors driving the marine biotechnology market in this region are a huge amount of research prevailing for marine biodiscovery and new molecule identification.
COMPETITIVE INSIGHTS
Aker Biomarine is a Norwegian marine biotechnology company that deals in krillbased nutrition supplements, pet food, and aquaculture products. BASF SE based in Germany is another marine biotech company that has a wide range of products and deals in sectors such as chemical, plastics, crop technology, and crude oil natural gas. Some of the other major players in the global market include Aker bio marine, Abbott, Lonza, New England Biolabs, and Biotech Marine Subsidiary Of Air Liquid Group
Original Article: GLOBAL MARINE BIOTECHNOLOGY MARKET FORECAST 20172026 [Report Updated: 15122017] Prices from USD $2500
NEXT ARTICLE